• BX Home
  • King Pharmaceuticals (KG): News

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

KING PHARMACEUTICALS (KG)

King Pharmaceuticals, Inc. is the world’s 39th-largest pharmaceutical company. It provides branded prescription pharmaceutical products worldwide It primarily offers branded prescription products for primary care physicians, neurologists, orthopedic surgeons, hospitals, internal medicine physicians, allergists, pediatricians, and pain specialists. Some brands include Altace for heart attack prevention; Levoxyl for hypothyroidism; Sonata for sleeping; and Skelaxin, a muscle relaxant.

King Pharmaceuticals (KG) is part of Business Exchange, suggested by Ginny Moore. This topic contains 196 news and 136 blog items. Read updated news, blogs, and resources about King Pharmaceuticals (KG). Find user-submitted articles and reactions on King Pharmaceuticals (KG) from like-minded professionals.

News

Recent news on this topic.

Which Drug Companies Could Be Private-Equity Targets?more

in debt as of the quarter ended Sept. 30 and has a market cap of $2.6 billion. King Pharmaceuticals sells generic drugs...

Research and Markets: Managed Markets Account Management: Assessing th...more

Pharmaceuticals * EMD Serono * AstraZeneca * Honeywell * Bayer Schering AG * IDS * Boehringer Ingelheim * King...

Your First Move For Friday November 20thmore

Spread In S&P Futures © 2009 CNBC.comTopics:Oil | Stock Market | Stock PicksSectors:Oil and GasCompanies:King...

Credit Cards Party, Bears Smell Blood At E*Trademore

to them at an effective price of $3.80 apiece if the put options land in-the-money by expiration. King Pharmaceuticals...

King Pharmaceuticals to Present at Lazard Capital Markets Healthcare C...more

Extract not available.

ZymoGenetics injunction liftedmore

Seattle-based biotechnology company said Friday. The three restraining orders resulted from a lawsuit filed by rival...

King Pharmaceuticals to Present at Credit Suisse Healthcare Conferencemore

Extract not available.

Earnings King of the Daymore

Fast Money Final Trades Airtime: ET A pharma insider gives an outlook for the sector, with Brian Markison, King...

A Conversation With King Pharma CEO Brian Markisonmore

Lee BrodieWeb ProducerDrug developer King Pharmaceuticals KGloading...� � �

Futures Edge Up with Retail Sales Comingmore

gas inventories. Companies set to release earnings this morning include Cardinal Health, Cigna, CVS Caremark, Dr Pepper...

King 3Q profit falls on charges, but tops forecastmore

deal. Its Meridian unit gained 6 percent to $72 million. Royalty revenue fell to $12 million. Shares of King...

Futures Push Higher on Economic Optimismmore

gas inventories. Companies set to release earnings this morning include Cardinal Health, Cigna, CVS Caremark, Dr Pepper...

King Pharma 3Q Net Falls 48%, But Results Beat Viewsmore

DOW JONES NEWSWIRES King Pharmaceuticals Inc.'s(KG) third-quarter profit slid 48% amid charges and a 34% jump in...

Fed Slows Momentum for Most ETFs (Daily ETF Wrap-Up)more

Game Technology, International Rectifier, Internet Capital Group , iPass, Isis Pharmaceuticals, JDSU, Jones Soda,...

UPDATE 1-King sues ZymoGenetics alleging trademark violationmore

co's marketing conducts related to Recothrom * ZymoGenetics seeks immediate relief from court Nov 4 (Reuters) - King...

DURECT Corporation Announces Third Quarter 2009 Financial Resultsmore

2009 period included $3.0 million related to the sale of certain excipients used in REMOXY(R) to King Pharmaceuticals...

King Pharmaceuticals Licenses Exclusive Rights to CYANOKIT® in U.S.more

BRISTOL, Tenn.--(Business Wire)-- King Pharmaceuticals, Inc. (NYSE:KG) announced today that it has licensed from Merck...

UPDATE 1-FDA declines to approve King's heart imaging drugmore

Oct 21 (Reuters) - King Pharmaceuticals Inc (KG.N) said U.S. health regulators declined to approve its heart imaging...

FDA Issues Complete Response Letter for CorVue(TM)more

(BUSINESS WIRE) -- King Pharmaceuticals, Inc. (NYSE: KG) announced today that the U.S. Food and Drug Administration...

King Pharma Imaging Agent Could Face FDA Delaymore

King Pharmaceuticals gets FDA request on stress imaging agent, potentially delaying approval

UPDATE 1-US FDA: King pain drug videos misleadingmore

stop using materials * Shares fall 2 percent WASHINGTON, Oct 20 (Reuters) - Two video news releases for King...

Bank Of America Brings Out The Bearsmore

call buyers may profit by expiration if shares of the EWZ rise at least 3% to $78.30. King Pharmaceuticals ( KG - news...

Cancer, bowel drugs on U.S. FDA safety scrutiny listmore

continue to monitor this issue closely,' Wyeth spokeswoman Gwen Fisher said. The FDA also said it was probing King...

Top NBC Series Talent to Direct One-Minute Film Shorts on Personal Res...more

Grill & Bar, Covidien, CVS/pharmacy, Dunkin' Donuts, Harvard Pilgrim Health Care, John Hancock, The J.M.

UPDATE 2-Cancer, bowel drugs on U.S. FDA safety scrutiny listmore

continue to monitor this issue closely,' Wyeth spokeswoman Gwen Fisher said. The FDA also said it was probing King...

Top Sources: King Pharmaceuticals (KG)

  • MarketWatch
  • Reuters
  • TheStreet.com
  • CNBC
  • BusinessWeek
  • Seattle Post Intelligencer
  • Miami Herald
  • biz.yahoo.com
  • Boston Globe
  • CNN Money

Most Active Users in this Topic

No user contributions

Featured White Papers


Report comment contains invalid characters. ()
cancel
Search Cancel